7.33
price up icon0.96%   0.07
after-market After Hours: 7.33
loading
Emergent Biosolutions Inc stock is traded at $7.33, with a volume of 634.63K. It is up +0.96% in the last 24 hours and down -14.07% over the past month. Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. Geographically, the company operates in United States, Canada, and Others. It derives maximum revenue from United states. The company's products include: NARCAN Nasal Spray, KLOXXADO Nasal Spray, ACAM2000, ANTHRASIL, BAT, BioThrax, CNJ-016, raxibacumab injection, Ebanga, and others.
See More
Previous Close:
$7.26
Open:
$7.36
24h Volume:
634.63K
Relative Volume:
0.78
Market Cap:
$378.20M
Revenue:
$676.80M
Net Income/Loss:
$-8.60M
P/E Ratio:
-25.91
EPS:
-0.2829
Net Cash Flow:
$135.40M
1W Performance:
-4.68%
1M Performance:
-14.07%
6M Performance:
-40.02%
1Y Performance:
+2.23%
1-Day Range:
Value
$7.2928
$7.50
1-Week Range:
Value
$7.235
$7.73
52-Week Range:
Value
$5.615
$14.06

Emergent Biosolutions Inc Stock (EBS) Company Profile

Name
Name
Emergent Biosolutions Inc
Name
Phone
240-631-3200
Name
Address
300 PROFESSIONAL DR, GAITHERSBURG, MD
Name
Employee
900
Name
Next Earnings Date
2026-08-05
Name
Latest SEC Filings
Name
EBS's Discussions on Twitter

Compare EBS vs TAK, HLN, TEVA, ZTS, UTHR

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
EBS icon
EBS
Emergent Biosolutions Inc
7.33 374.59M 676.80M -8.60M 135.40M -0.2829
TAK icon
TAK
Takeda Pharmaceutical Co Adr
17.44 55.06B 29.91B 1.30B 3.49B 0.4056
HLN icon
HLN
Haleon Plc Adr
9.94 43.07B 14.54B 2.22B 2.58B 0.4871
TEVA icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
31.08 35.88B 17.53B 1.58B 444.18M 1.3457
ZTS icon
ZTS
Zoetis Inc
76.92 31.59B 9.51B 2.64B 2.14B 6.0361
UTHR icon
UTHR
United Therapeutics Corp
527.94 26.32B 3.17B 1.29B 1.01B 27.09

Emergent Biosolutions Inc Stock (EBS) Upgrades & Downgrades

Date Action Analyst Rating Change
Dec-30-24 Initiated H.C. Wainwright Buy
Aug-22-24 Initiated Rodman & Renshaw Buy
Mar-07-24 Upgrade The Benchmark Company Hold → Buy
Nov-20-23 Resumed JP Morgan Underweight
Aug-29-23 Downgrade The Benchmark Company Buy → Hold
Apr-10-23 Upgrade The Benchmark Company Hold → Buy
Mar-17-23 Downgrade JP Morgan Neutral → Underweight
Nov-10-22 Downgrade The Benchmark Company Buy → Hold
Apr-29-22 Downgrade Cantor Fitzgerald Overweight → Neutral
Jan-20-22 Upgrade The Benchmark Company Hold → Buy
Nov-08-21 Downgrade The Benchmark Company Buy → Hold
May-05-21 Downgrade Argus Buy → Hold
Apr-07-21 Initiated The Benchmark Company Buy
Feb-24-21 Upgrade Chardan Capital Markets Neutral → Buy
Feb-19-21 Downgrade Chardan Capital Markets Buy → Neutral
Jan-08-21 Downgrade Wells Fargo Overweight → Equal Weight
Sep-14-20 Resumed JP Morgan Neutral
Jul-31-20 Reiterated Chardan Capital Markets Buy
Sep-12-19 Initiated Guggenheim Buy
Sep-04-19 Upgrade Wells Fargo Market Perform → Outperform
Nov-02-18 Upgrade Goldman Neutral → Buy
Aug-03-18 Reiterated Chardan Capital Markets Buy
Jun-13-18 Initiated Argus Buy
Apr-25-18 Downgrade Wells Fargo Outperform → Market Perform
Jan-24-18 Initiated Goldman Neutral
Jan-16-18 Reiterated Chardan Capital Markets Buy
Jun-28-16 Reiterated Singular Research Buy
Apr-15-16 Initiated Chardan Capital Markets Buy
Mar-28-16 Initiated Singular Research Buy
Feb-19-16 Initiated Wells Fargo Outperform
May-15-14 Initiated Summer Street Research Buy
May-31-11 Reiterated WBB Securities Strong Buy
Jan-10-11 Reiterated Wedbush Outperform
Nov-05-10 Reiterated Wedbush Outperform
Aug-18-10 Upgrade WBB Securities Buy → Strong Buy
Aug-06-10 Reiterated Caris & Company Buy
View All

Emergent Biosolutions Inc Stock (EBS) Latest News

pulisher
04:40 AM

Emergent BioSolutions Inc (EBS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

04:40 AM
pulisher
Jul 25, 2026

TradingKey - TradingKey

Jul 25, 2026
pulisher
Jul 25, 2026

EBS|Emergent BioSolutions Inc|Price:7.260| - TradingKey

Jul 25, 2026
pulisher
Jul 25, 2026

EBS|Emergent BioSolutions Inc|Price:7.260|Chg%:-0.240 - TradingKey

Jul 25, 2026
pulisher
Jul 24, 2026

EBS5025997 Bond Risk Profile - TradingView

Jul 24, 2026
pulisher
Jul 24, 2026

EBS5025997 Bond Profile — Key Metrics - TradingView

Jul 24, 2026
pulisher
Jul 24, 2026

Emergent BioSolutions Inc (EBS) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Jul 24, 2026
pulisher
Jul 23, 2026

Emergent BioSolutions to report Q2 2026 results on August 5 - scanx.trade

Jul 23, 2026
pulisher
Jul 22, 2026

Emergent BioSolutions to Report Second Quarter 2026 Financial Results on August 5, 2026 - The Manila Times

Jul 22, 2026
pulisher
Jul 22, 2026

Emergent BioSolutions offers live webcast for Aug. 5 results call - Stock Titan

Jul 22, 2026
pulisher
Jul 16, 2026

Emergent BioSolutions (EBS) AGM 2026 Summary - Quartr

Jul 16, 2026
pulisher
Jul 16, 2026

Emergent BioSolutions (EBS) Q3 2024 earnings summary - Quartr

Jul 16, 2026
pulisher
Jul 16, 2026

Emergent BioSolutions (EBS) Proxy filing Summary - Quartr

Jul 16, 2026
pulisher
Jul 16, 2026

Emergent BioSolutions (EBS) Q1 2026 earnings summary - Quartr

Jul 16, 2026
pulisher
Jul 14, 2026

Lobbying Update: $510,000 of EMERGENT BIOSOLUTIONS INC lobbying was just disclosed - Quiver Quantitative

Jul 14, 2026
pulisher
Jul 14, 2026

EBS5025998 Bond Profile — Key Metrics - TradingView

Jul 14, 2026
pulisher
Jul 14, 2026

EBS5025998 Bond Coupon Profile — Rate & Payments - TradingView

Jul 14, 2026
pulisher
Jul 14, 2026

Price to sales forward of Emergent BioSolutions Inc. – LS:A0LC2W - TradingView

Jul 14, 2026
pulisher
Jul 09, 2026

Why Did Emergent Biosolutions Stock Tumble 20% After-Hours Today? - Stocktwits

Jul 09, 2026
pulisher
Jul 08, 2026

Emergent BioSolutions Inc. (NYSE:EBS) Shares Sold by Mutual of America Capital Management LLC - 富途牛牛

Jul 08, 2026
pulisher
Jul 07, 2026

Emergent BioSolutions Company Profile & Introduction - Moomoo

Jul 07, 2026
pulisher
Jul 06, 2026

Emergent BioSolutions highlights its role in specialty vaccines as investors weigh the long-term out - Ad-hoc-news.de

Jul 06, 2026
pulisher
Jul 03, 2026

Insider Sell: Paul Williams Sells 3,000 Shares of Emergent BioSo - GuruFocus

Jul 03, 2026
pulisher
Jul 02, 2026

Emergent BioSolutions | 4: Statement of changes in beneficial ownership of securities-Officer Williams Paul Anthony - Moomoo

Jul 02, 2026
pulisher
Jul 02, 2026

Emergent BioSolutions SVP Williams sells $25,200 in common stock By Investing.com - Investing.com Nigeria

Jul 02, 2026
pulisher
Jul 02, 2026

Emergent BioSolutions SVP Williams sells $25,200 in common stock - Investing.com

Jul 02, 2026
pulisher
Jul 02, 2026

Form 4 Emergent Biosolutions Inc For: 2 July By Investing.com - Investing.com Canada

Jul 02, 2026
pulisher
Jul 02, 2026

Emergent BioSolutions (EBS) SVP sells 3,000 shares under plan - Stock Titan

Jul 02, 2026
pulisher
Jul 01, 2026

Emergent BioSolutions | 144: Notice of proposed sale of securities pursuant to Rule 144 - Moomoo

Jul 01, 2026
pulisher
Jul 01, 2026

[144] Emergent BioSolutions Inc. SEC Filing - Stock Titan

Jul 01, 2026
pulisher
Jun 29, 2026

Emergent BioSolutions Secures Contract Modification Valued At Approximately USD 52.7 Million From The United States Department Of Health And Human Services To Supply ACAM2000 - marketscreener.com

Jun 29, 2026
pulisher
Jun 29, 2026

Emergent BioSolutions Secures New ACAM2000 Biodefense Contract - TipRanks

Jun 29, 2026
pulisher
Jun 29, 2026

Emergent BioSolutions (NYSE: EBS) lands $52.7M U.S. ACAM2000 contract - Stock Titan

Jun 29, 2026
pulisher
Jun 29, 2026

symbol__ Stock Quote Price and Forecast - CNN

Jun 29, 2026
pulisher
Jun 29, 2026

Emergent BioSolutions (EBS) Secures $52.7M Contract for Smallpox Vaccine Supply - GuruFocus

Jun 29, 2026
pulisher
Jun 29, 2026

Emergent BioSolutions wins $52.7m smallpox vaccine contract By Investing.com - Investing.com South Africa

Jun 29, 2026
pulisher
Jun 29, 2026

Emergent BioSolutions wins $52.7m smallpox vaccine contract - Investing.com

Jun 29, 2026
pulisher
Jun 29, 2026

U.S. government adds $52.7M ACAM2000 order for smallpox preparedness - Stock Titan

Jun 29, 2026
pulisher
Jun 26, 2026

Emergent BioSolutions Inc. Actuals & Estimates (NYSE:EBS) - TradingView

Jun 26, 2026
pulisher
Jun 26, 2026

Emergent BioSolutions | 8-K: Current report - Moomoo

Jun 26, 2026
pulisher
Jun 26, 2026

Emergent BioSolutions Inc. Actuals & Estimates (BOATS:EBS) - TradingView

Jun 26, 2026
pulisher
Jun 26, 2026

EBS Forecast — Price Target — Prediction for 2027 - TradingView

Jun 26, 2026
pulisher
Jun 25, 2026

Price to earnings forward of Emergent BioSolutions Inc. – NYSE:EBS - TradingView

Jun 25, 2026
pulisher
Jun 25, 2026

Enterprise value to revenue forward of Emergent BioSolutions Inc. – BOATS:EBS - TradingView

Jun 25, 2026
pulisher
Jun 25, 2026

Price to sales forward of Emergent BioSolutions Inc. – NYSE:EBS - TradingView

Jun 25, 2026
pulisher
Jun 24, 2026

Emergent Biosolutions studies intranasal naloxone for opioid overdose response - Traders Union

Jun 24, 2026
pulisher
Jun 24, 2026

Emergent BioSolutions Inc (EBS) Valuation: PE, PB & Fair Value Analysis - TradingKey

Jun 24, 2026
pulisher
Jun 23, 2026

Emergent BioSolutions Inc (EBS) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Jun 23, 2026
pulisher
Jun 21, 2026

Emergent BioSolutions StockSunday background on the business and risk profile - AD HOC NEWS

Jun 21, 2026
pulisher
Jun 18, 2026

Why Emergent’s Narcan nasal spray is becoming a quiet everyday life saver - Ad-hoc-news.de

Jun 18, 2026
pulisher
Jun 18, 2026

Emergent BioSolutions Inc (EBS) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Jun 18, 2026

Emergent Biosolutions Inc Stock (EBS) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$52.73
price down icon 0.30%
RDY RDY
$11.77
price down icon 0.17%
$25.41
price up icon 2.01%
$176.41
price up icon 0.36%
$17.64
price up icon 2.29%
$527.94
price down icon 0.10%
Cap:     |  Volume (24h):